Bioburden Determination - Preclinical Medical Device Testing Services Market
The global bioburden determination preclinical medical device testing services market size was valued at US$ 225.3 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 9% from 2024 to 2030.